Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Advanced Prostate Carcinoma × darolutamide × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 9 Non-metastatic Castration-resistant Prostate Cancer 2 Prostate Cancer Non-Metastatic 1 Neoplasms 1 Metastatic Hormone-sensitive Prostate Cancer 1 Healthy Volunteers 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Breast Cancer Female 1 Biochemically Recurrent Prostate Cancer 1 Advanced Prostate Carcinoma 1

Interventions

enzalutamide 1 darolutamide 1 apalutamide 1 abiraterone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05612880 2025-01-09

Physical Function During ARSI Treatment

UNC Lineberger Comprehensive Cancer Center

Advanced Prostate Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡